1 Growth Stock Down 40% to Buy Right Now

Celsius (CELH) stock has recently fallen 43% from its mid-May peak, driven by a deceleration in growth as its U.S. distribution reached 98% ACV, leading to Q1 revenue growth of 37% year-over-year compared to 95% in Q4, and a slight market share dip. Despite this, the company retains significant growth potential through continued U.S. shelf space expansion, new product innovation like Celsius Essentials, and early-stage international market penetration in regions such as the UK and Australia. The recent correction has also made its valuation more attractive, with a forward P/E below 50 and a PEG ratio of 1.1x, suggesting a potential buying opportunity for a growth stock with a long runway.

Analysis

Celsius (CELH) stock has recently experienced a significant 43% decline from its mid-May peak, despite a remarkable 4,400% gain over the past five years. This downturn is primarily attributed to a notable deceleration in revenue growth, with Q1 2024 reporting 37% year-over-year growth to $355.7 million, a sharp drop from 95% in Q4 2023. The U.S. market has reached near saturation, indicated by a 98% all-commodity volume (ACV), suggesting limited further expansion through distribution channels.

Concurrently, Celsius's U.S. market share slightly decreased from 10.7% in early May to 9.6% by mid-June, although it remains the largest year-over-year market share winner. This competitive environment is intensifying as rivals, including Monster Beverage and Alani Nu, actively target the female demographic that Celsius initially pioneered. Nielsen data further corroborates a growth slowdown, showing rates in the 20% range.

Despite recent headwinds, Celsius retains several potential growth catalysts. Domestically, the company anticipates gaining additional shelf space and improved product placements, particularly for its Celsius Essentials line, following a delayed spring shelving reset. International expansion presents a substantial long-term opportunity, with early success in Scandinavian markets and nascent entries into the U.K. and Australia, though establishing strong distribution partners in other regions like Latin America and Asia will be crucial.

The recent stock correction has rendered Celsius's valuation more attractive, with its forward price-to-earnings (P/E) ratio now below 50, compared to Monster's 28 P/E with significantly lower growth. Furthermore, Celsius's price/earnings-to-growth (PEG) ratio of 1.1x is considered appealing for a growth stock, especially when contrasted with Monster's 1.8x PEG. This suggests a potentially undervalued growth opportunity given its market position and innovation pipeline.

Key Decisions for Investors

• Monitor Celsius's execution on U.S. shelf space expansion and the performance of new product innovations like Celsius Essentials, as these are critical near-term growth drivers.
• Evaluate the progress of international market penetration and the establishment of new distribution partnerships, which represent significant long-term growth potential beyond U.S. market saturation.
• Consider the current valuation metrics, specifically the forward P/E below 50 and PEG ratio of 1.1x, as the recent stock decline may present an attractive entry point for a growth-oriented investment.